STOCK MARKET BSE NSE

FDA approved drug 'Teicoplanin' found more effective in treating COVID-19: IIT Delhi research

Published: 30th September 2020 12:49 PM  |   Last Updated: 30th September 2020 12:50 PM  

Clinically approved drug "Teicoplanin" is a potential therapeutic option against #COVID19 and can be ten times more effective than several drugs being currently used, a research by Indian Institute of Technology (IIT), Delhi has found.

TAGS
covid 19

Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

IPL_2020
flipboard facebook twitter whatsapp